Brought to you by 
PerkinElmer buys Sym-Bio LifeScience for $63.7mm in cash
29 Sep 2009
Executive Summary
To gain access to the rapidly growing diagnostics market in China, PerkinElmer is paying $63.7mm in cash to acquire Sym-Bio LifeScience, a leading Chinese developer of diagnostic instruments and related reagents.
Deal Industry
- In Vitro Diagnostics
- Research, Analytical Equipment & Supplies
-
Medical Devices
- Diagnostic Equipment & Supplies
-
In Vitro Diagnostics
- Chemistry, Immunoassay
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
PerkinElmer buys Sym-Bio LifeScience for $63.7mm in cash
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice